免疫和炎性疾病的低剂量白介素-2治疗:临床应用和前景

作     者：栗占国 何菁 苗苗 Zhan-Guo Li;Jing He;Miao Miao

作者机构：Department of Rheumatology and ImmunologyBeijing Key Laboratory for Rheumatism and Immune DiagnosisPeking University People's HospitalBeijing 100044China Peking-Tsinghua Center for Life SciencesBeijing 100871China 

出 版 物：《Science Bulletin》 (科学通报（英文版）)

年 卷 期：2023年第68卷第1期

页      面：10-13页

核心收录：

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 100401[医学-流行病与卫生统计学] 10[医学] 

基　　金：supported by the National Natural Science Foundation of China(32141004 and U1903210) Macao Science and Technology Fund(0094/2018/A3) Beijing Science and Technology Program(Z191100006619114) 

主　　题：impaired 炎性疾病 diseases 

摘      要：Autoimmune diseases(AIDs)are characterized by impaired function of regulatory T(Treg)cells and excessive activation of effector T(Teff)*** agents and corticosteroids have long been the cornerstone of treatment for these ***,these medications may cause life-threatening infections and other severe adverse *** resolve this dilemma,safe and more effective therapeutic approaches are urgently needed.